Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Recurrence × Immunoconjugates × 1 year × Clear all

Sponsor

Conditions

Neoplasms 2 Neoplasm Metastasis 2 Breast Neoplasms 2 Prostatic Neoplasms 1 Brain Neoplasms 1 Alopecia 1

Interventions

Cyclophosphamide 37 venetoclax 27 fludarabine 27 Dexamethasone 26 pembrolizumab 20 Rituximab 17 Gemcitabine 16 pomalidomide 14 Cytarabine 14 Lenalidomide 12 Nivolumab 11 fludarabine phosphate 10 carfilzomib 10 Temozolomide 10 Etoposide 10 Azacitidine 10 Injections 9 Calcium Dobesilate 9 obinutuzumab 8 glofitamab 8 daratumumab 8 Cisplatin 7 Capecitabine 7 Bevacizumab 7 zanubrutinib 6 selinexor 6 ruxolitinib 6 ibrutinib 6 cemiplimab 6 Decitabine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡